WANG Tang-shun, CHEN Xiao-heng, DING Zhi-guo, et al. Clinical Studies in Treatment of Middle-late Stage Primary Liver Cancer with Shenqi Fuzheng Injection Combined with Interferon-[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(18): 174-177.
DOI:
WANG Tang-shun, CHEN Xiao-heng, DING Zhi-guo, et al. Clinical Studies in Treatment of Middle-late Stage Primary Liver Cancer with Shenqi Fuzheng Injection Combined with Interferon-[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(18): 174-177. DOI: 10.13422/j.cnki.syfjx.2014180174.
Clinical Studies in Treatment of Middle-late Stage Primary Liver Cancer with Shenqi Fuzheng Injection Combined with Interferon-
Objective: To investigate Shenqi Fuzheng injection in combination with interferon-α treatment of advanced primary liver cancer clinical efficacy and adverse reactions. Method: A retrospective case studies selected has lost surgery
radiotherapy and chemotherapy alone in patients with advanced hepatocellular carcinoma and combined interferon-α and interferon-α Shenqi Fuzheng injection rate of tumor regression in patients
survival
Karnofsky functional status score(KPS)
weight changes and side effects of treatment during the study comparing the treatment of poisoning. Result: The combination group in tumor shrinkage rate
survival
KPS score
weight changes during treatment and side effects of treatment of poisoning are better than interferon-α alone group. Conclusion: Shenqi Fuzheng injection combination with interferon-α play a synergistic role in the treatment of advanced primary liver cancer when
there is a unique effect in prolong survival and improve quality of life for patients
the adverse reactions were mild and worth clinical application.